CA Patent

CA2373035A1 — 3a,4,5,9b-tetrahydro-1h-benz[e]indol-2-yl amine-derived neuropeptide y receptors ligands useful in the treatment of obesity and other disorders

Assigned to Janssen Pharmaceuticals Inc · Expires 2000-11-16 · 26y expired

What this patent protects

Compounds of formula: (A) are disclosed as ligands for neuropeptide Y receptors and as such are useful in the treatment of obesity and disorders o f the central nervous system.

USPTO Abstract

Compounds of formula: (A) are disclosed as ligands for neuropeptide Y receptors and as such are useful in the treatment of obesity and disorders o f the central nervous system.

Drugs covered by this patent

Patent Metadata

Patent number
CA2373035A1
Jurisdiction
CA
Classification
—
Expires
2000-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.